María del Carmen
Berasain Lasarte
Catedrática de Universidad
Carlos Manuel
Rodríguez Ortigosa
Investigador hasta 2021
Publicaciones en las que colabora con Carlos Manuel Rodríguez Ortigosa (11)
2019
-
Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma
Hepatology, Vol. 69, Núm. 2, pp. 587-603
-
Splicing events in the control of genome integrity: Role of SLU7 and truncated SRSF3 proteins
Nucleic Acids Research, Vol. 47, Núm. 7, pp. 3450-3466
-
The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids Synthesis
Hepatology, Vol. 69, Núm. 4, pp. 1632-1647
2018
-
Bile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 4, pp. 1326-1334
2017
-
Engineered fibroblast growth factor 19 protects from acetaminophen-induced liver injury and stimulates aged liver regeneration in mice
Cell Death and Disease, Vol. 8, Núm. 10
-
Fibroblast Growth Factor 15/19 in Hepatocarcinogenesis
Digestive Diseases, Vol. 35, Núm. 3, pp. 158-165
-
Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: Development of an FGF19-based chimeric molecule to promote fatty liver regeneration
Gut, Vol. 66, Núm. 10, pp. 1818-1828
2012
-
Lack of Abcc3 expression impairs bile-acid induced liver growth and delays hepatic regeneration after partial hepatectomy in mice
Journal of Hepatology, Vol. 56, Núm. 2, pp. 367-373
2010
2009
-
The epidermal growth factor receptor ligand amphiregulin is a negative regulator of hepatic acute-phase gene expression
Journal of Hepatology, Vol. 51, Núm. 6, pp. 1010-1020
2002
-
Altered liver gene expression in CCl4-cirrhotic rats is partially normalized by insulin-like growth factor-I
International Journal of Biochemistry and Cell Biology, Vol. 34, Núm. 3, pp. 242-252